Cortagen — Khavinson bioregulator — heart / cardiac
Cortagen targets cardiac tissue. Proposed to activate cardiomyocyte-specific gene expression programs that decline with aging. Animal studies show improved myocardial recovery after ischemia, enhanced mitochondrial respiration, ATP synthesis improvement, and reduced oxidative stress. Limited clinical data.
نظرة عامة
هذه الصفحة جزء من مكتبة المركّبات المُصنَّفة بالأدلة في Hormonaly. جميع الادعاءات السريرية مرتبطة بمصادر علمية مُحكَّمة عبر خط أنابيب التحقق المزدوج للاستشهادات.
فئة المركّب
Khavinson bioregulator — heart / cardiac
آلية العمل
Cortagen targets cardiac tissue. Proposed to activate cardiomyocyte-specific gene expression programs that decline with aging. Animal studies show improved myocardial recovery after ischemia, enhanced mitochondrial respiration, ATP synthesis improvement, and reduced oxidative stress. Limited clinical data.
الوضع التنظيمي
Not FDA approved. Research peptide. Not approved as pharmaceutical drug in Russia.
مستوى الأدلة
Very Low — animal studies (Korkushko et al.) and limited small clinical observations only. No published RCTs in humans.